Detalhe da pesquisa
1.
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Int J Cancer
; 148(2): 385-395, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965028
2.
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223.
Eur J Nucl Med Mol Imaging
; 48(10): 3325-3334, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686456
3.
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer.
Future Oncol
; 16(19): 1371-1384, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469606
4.
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.
Br J Clin Pharmacol
; 84(5): 1064-1067, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29384591
5.
Results of primary versus recurrent surgery to treat stress urinary incontinence in women.
Int Urogynecol J
; 26(7): 997-1005, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25752467
6.
The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients.
J Nucl Med
; 65(4): 541-547, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423781
7.
Tumoral Ki67 and PSMA Expression in Fresh Pre-PSMA-RLT Biopsies and Its Relation With PSMA-PET Imaging and Outcomes of PSMA-RLT in Patients With mCRPC.
Clin Genitourin Cancer
; 21(5): e352-e361, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164814
8.
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy.
Prostate Cancer Prostatic Dis
; 26(1): 142-150, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804188
9.
Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 25(1): 71-78, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253846
10.
Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
Front Oncol
; 11: 667658, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34084750
11.
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy.
Urol Oncol
; 39(10): 729.e7-729.e16, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33353867
12.
Results of the York Mason Procedure with and without Concomitant Graciloplasty to Treat Iatrogenic Rectourethral Fistulas.
Eur Urol Focus
; 6(4): 762-769, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402242
13.
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.
Eur J Cancer
; 136: 16-24, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634759
14.
Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives.
Clin Genitourin Cancer
; 17(2): 79-87, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30558834
15.
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice.
Clin Nucl Med
; 43(1): 9-16, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29166331
16.
Response to comment on "Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer".
Eur J Cancer
; 144: 395-396, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358841